Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection.

Burke KP, Munshaw S, Osburn WO, Levine J, Liu L, Sidney J, Sette A, Ray SC, Cox AL.

J Immunol. 2012 May 15;188(10):5177-88. doi: 10.4049/jimmunol.1103008. Epub 2012 Apr 16.

2.

Synthetic poliovirus and other designer viruses: what have we learned from them?

Wimmer E, Paul AV.

Annu Rev Microbiol. 2011;65:583-609. doi: 10.1146/annurev-micro-090110-102957. Review.

PMID:
21756105
3.

Hepatitis in 2010: the dawn of a new era in HCV therapy.

Ciesek S, Manns MP.

Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):69-71. doi: 10.1038/nrgastro.2010.219. Review.

PMID:
21293503
4.

Enhanced protocol for determining the 3' terminus of hepatitis C virus.

Zhang X, Fan X, Xu Y, Di Bisceglie AM.

J Virol Methods. 2010 Aug;167(2):158-64. doi: 10.1016/j.jviromet.2010.03.030. Epub 2010 Apr 8.

5.

Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.

Liu L, Fisher BE, Dowd KA, Astemborski J, Cox AL, Ray SC.

J Virol. 2010 May;84(10):5067-77. doi: 10.1128/JVI.02265-09. Epub 2010 Mar 3.

6.

Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys.

Barouch DH, O'Brien KL, Simmons NL, King SL, Abbink P, Maxfield LF, Sun YH, La Porte A, Riggs AM, Lynch DM, Clark SL, Backus K, Perry JR, Seaman MS, Carville A, Mansfield KG, Szinger JJ, Fischer W, Muldoon M, Korber B.

Nat Med. 2010 Mar;16(3):319-23. doi: 10.1038/nm.2089. Epub 2010 Feb 21.

7.

Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity.

Yusim K, Fischer W, Yoon H, Thurmond J, Fenimore PW, Lauer G, Korber B, Kuiken C.

J Gen Virol. 2010 May;91(Pt 5):1194-206. doi: 10.1099/vir.0.017491-0. Epub 2010 Jan 6.

PMID:
20053820
8.

Hepatitis C virus recombinants are rare even among intravenous drug users.

Viazov S, Ross SS, Kyuregyan KK, Timm J, Neumann-Haefelin C, Isaeva OV, Popova OE, Dmitriev PN, El Sharkawi F, Thimme R, Michailov MI, Roggendorf M.

J Med Virol. 2010 Feb;82(2):232-8. doi: 10.1002/jmv.21631.

PMID:
20029799
9.

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.

Osburn WO, Fisher BE, Dowd KA, Urban G, Liu L, Ray SC, Thomas DL, Cox AL.

Gastroenterology. 2010 Jan;138(1):315-24. doi: 10.1053/j.gastro.2009.09.017. Epub 2009 Sep 24.

10.

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M.

Nature. 2009 Oct 8;461(7265):798-801. doi: 10.1038/nature08463.

11.

Rare birds in North America: acute hepatitis C cohorts.

Cox AL, Page K, Bruneau J, Shoukry NH, Lauer GM, Kim AY, Rosen HR, Radziewicz H, Grakoui A, Fierer DS, Branch AD, Kaplan DE, Chang KM.

Gastroenterology. 2009 Jan;136(1):26-31. doi: 10.1053/j.gastro.2008.11.049. Epub 2008 Dec 4. No abstract available.

12.

Acute hepatitis C.

Maheshwari A, Ray S, Thuluvath PJ.

Lancet. 2008 Jul 26;372(9635):321-32. doi: 10.1016/S0140-6736(08)61116-2. Review.

PMID:
18657711
13.

Hepatitis C virus entry and neutralization.

Stamataki Z, Grove J, Balfe P, McKeating JA.

Clin Liver Dis. 2008 Aug;12(3):693-712, x. doi: 10.1016/j.cld.2008.03.008. Review.

PMID:
18625435
14.

Analysis of the evolutionary forces in an immunodominant CD8 epitope in hepatitis C virus at a population level.

Neumann-Haefelin C, Frick DN, Wang JJ, Pybus OG, Salloum S, Narula GS, Eckart A, Biezynski A, Eiermann T, Klenerman P, Viazov S, Roggendorf M, Thimme R, Reiser M, Timm J.

J Virol. 2008 Apr;82(7):3438-51. doi: 10.1128/JVI.01700-07. Epub 2008 Jan 23. Erratum in: J Virol. 2011 May;85(9):4634.

15.

3' RNA elements in hepatitis C virus replication: kissing partners and long poly(U).

You S, Rice CM.

J Virol. 2008 Jan;82(1):184-95. Epub 2007 Oct 17.

16.

Founder effects in the assessment of HIV polymorphisms and HLA allele associations.

Bhattacharya T, Daniels M, Heckerman D, Foley B, Frahm N, Kadie C, Carlson J, Yusim K, McMahon B, Gaschen B, Mallal S, Mullins JI, Nickle DC, Herbeck J, Rousseau C, Learn GH, Miura T, Brander C, Walker B, Korber B.

Science. 2007 Mar 16;315(5818):1583-6.

17.

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.

von Hahn T, Yoon JC, Alter H, Rice CM, Rehermann B, Balfe P, McKeating JA.

Gastroenterology. 2007 Feb;132(2):667-78. Epub 2006 Dec 3.

PMID:
17258731
18.

A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes.

Kuiken C, Combet C, Bukh J, Shin-I T, Deleage G, Mizokami M, Richardson R, Sablon E, Yusim K, Pawlotsky JM, Simmonds P; Los Alamos HIV Database Group.

Hepatology. 2006 Nov;44(5):1355-61. No abstract available.

PMID:
17058236
19.

Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells.

Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM.

Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2310-5. Epub 2006 Feb 6.

20.

Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection.

Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, Roggendorf M, von Weizs├Ącker F, Blum HE, Thimme R.

Hepatology. 2005 Oct;42(4):828-37.

PMID:
16175596

Supplemental Content

Support Center